Covid-19
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Definition of Participant (Phase I and Phase II/III): Administration of the investigational product/placebo on day 1 of the vaccination study. Definition of Screen Failure (Phase I and Phase II/III): Exclusion during screening at the trial site. Definition of Interested Person: Expression of interest in participation in vaccination study and provisioning of e-mail address. No invitation to screening. Inclusion criterion for online questionnaire: Belonging to one of the above-mentioned groups as well as completion and sending of the questionnaire.
Exclusion criteria
Exclusion criteria: Obviously incorrect/inconsistent completion of the questionnaire
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant differences and correlations in demographics, motivation, and attitudes towards risk, communication and technologies both within and across collectives. | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of the participants' risk behaviour with their self-assessment and comparison of the self-assessment with the total population. Checking the consistency of the stated motivation. Evaluation of the correlation between altruistic motivation and altruistic action. | — |
Countries
Germany
Contacts
Tropeninstitut am LMU Klinikum